Cargando…

Tumour-educated platelets for breast cancer detection: biological and technical insights

BACKGROUND: Studies have shown that blood platelets contain tumour-specific mRNA profiles tumour-educated platelets (TEPs). Here, we aim to train a TEP-based breast cancer detection classifier. METHODS: Platelet mRNA was sequenced from 266 women with stage I–IV breast cancer and 212 female controls...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liefaard, Marte C., Moore, Kat S., Mulder, Lennart, van den Broek, Daan, Wesseling, Jelle, Sonke, Gabe S., Wessels, Lodewyk F. A., Rookus, Matti, Lips, Esther H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070267/ https://www.ncbi.nlm.nih.gov/pubmed/36765174 http://dx.doi.org/10.1038/s41416-023-02174-5

Ejemplares similares

Correction To: Tumour-educated platelets for breast cancer detection: biological and technical insights
por: Liefaard, Marte C., et al.
Publicado: (2023)

Deep (phospho)proteomics profiling of pre- treatment needle biopsies identifies signatures of treatment resistance in HER2(+) breast cancer
por: Debets, Donna O., et al.
Publicado: (2023)

Comprehensive characterization of pre- and post-treatment samples of breast cancer reveal potential mechanisms of chemotherapy resistance
por: Hoogstraat, Marlous, et al.
Publicado: (2022)

Proteomic profiling of extracellular vesicles allows for human breast cancer subtyping
por: Rontogianni, Stamatia, et al.
Publicado: (2019)

Efficacy of neoadjuvant treatment with or without pertuzumab in patients with stage II and III HER2-positive breast cancer: a nationwide cohort analysis of pathologic response and 5-year survival
por: van der Voort, Anna, et al.
Publicado: (2022)

Next generation sequencing of triple negative breast cancer to find predictors for chemotherapy response
por: Lips, Esther H., et al.
Publicado: (2015)

Quantitative copy number analysis by Multiplex Ligation-dependent Probe Amplification (MLPA) of BRCA1-associated breast cancer regions identifies BRCAness
por: Lips, Esther H, et al.
Publicado: (2011)

Pathologic response of ductal carcinoma in situ to neoadjuvant systemic treatment in HER2-positive breast cancer
por: Groen, Emma J., et al.
Publicado: (2021)

Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy
por: Vollebergh, Marieke A, et al.
Publicado: (2014)

Evaluation of the EGFR polymorphism R497K in two cohorts of neoadjuvantly treated breast cancer patients
por: Sobral-Leite, Marcelo, et al.
Publicado: (2017)

Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ
por: Almekinders, Mathilde M. M., et al.
Publicado: (2021)

Breast Cancer Subtype Specific Classifiers of Response to Neoadjuvant Chemotherapy Do Not Outperform Classifiers Trained on All Subtypes
por: de Ronde, Jorma J., et al.
Publicado: (2014)

PROACTING: predicting pathological complete response to neoadjuvant chemotherapy in breast cancer from routine diagnostic histopathology biopsies with deep learning
por: Aswolinskiy, Witali, et al.
Publicado: (2023)

Lack of Genomic Heterogeneity at High-Resolution aCGH between Primary Breast Cancers and Their Paired Lymph Node Metastases
por: Vollebergh, Marieke A., et al.
Publicado: (2014)

BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancer
por: Liefaard, M. C., et al.
Publicado: (2023)

Enrichment of high-grade tumors in breast cancer gene expression studies
por: van Seijen, M., et al.
Publicado: (2017)

Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response
por: Lips, E. H., et al.
Publicado: (2013)

Tumour ablation: technical aspects
por: Widmann, Gerlig, et al.
Publicado: (2009)

Biological and technical factors in the assessment of blood-based tumor mutational burden (bTMB) in patients with NSCLC
por: Schuurbiers, Milou, et al.
Publicado: (2022)

Immune landscape of breast tumors with low and intermediate estrogen receptor expression
por: Voorwerk, Leonie, et al.
Publicado: (2023)

A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive progression
por: Hutten, Stefan J., et al.
Publicado: (2023)

Contralateral parenchymal enhancement on MRI is associated with tumor proteasome pathway gene expression and overall survival of early ER+/HER2-breast cancer patients
por: Ragusi, Max A.A., et al.
Publicado: (2021)

RUBIC identifies driver genes by detecting recurrent DNA copy number breaks
por: van Dyk, Ewald, et al.
Publicado: (2016)

Interaction of platelets and tumour cells
por: Schor, A.
Publicado: (1983)

Engineering platelets for tumour targeting
por: Marriott, Gerard
Publicado: (2016)

BRCAness digitalMLPA profiling predicts benefit of intensified platinum-based chemotherapy in triple-negative and luminal-type breast cancer
por: Lips, Esther H., et al.
Publicado: (2020)

Technical developments in transurethral resection of bladder tumours
por: Pastuszak, Agata, et al.
Publicado: (2019)

Additional value of (18)F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancer
por: van Ramshorst, Mette S., et al.
Publicado: (2017)

High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trial
por: Vliek, Sonja, et al.
Publicado: (2023)

Responders to Platelet-Rich Plasma in Osteoarthritis: A Technical Analysis
por: Milants, Christophe, et al.
Publicado: (2017)

Ductal carcinoma in situ: to treat or not to treat, that is the question
por: van Seijen, Maartje, et al.
Publicado: (2019)

The Facilitating Role of Chemotherapy in the Palliative Phase of Cancer: Qualitative Interviews with Advanced Cancer Patients
por: Buiting, Hilde M., et al.
Publicado: (2013)

Combining variant detection and fragment length analysis improves detection of minimal residual disease in postsurgery circulating tumour DNA of stage II–IIIA NSCLC patients
por: Vessies, Daan C. L., et al.
Publicado: (2022)

A Retrospective Study on the Use of Dermis Micrografts in Platelet-Rich Fibrin for the Resurfacing of Massive and Chronic Full-Thickness Burns
por: Andreone, Alessandro, et al.
Publicado: (2019)

Genome-wide epigenetic profiling of breast cancer tumors treated with aromatase inhibitors
por: Nevedomskaya, Ekaterina, et al.
Publicado: (2014)

Approximating multivariate posterior distribution functions from Monte Carlo samples for sequential Bayesian inference
por: Thijssen, Bram, et al.
Publicado: (2020)

Combinatorial effects of environmental parameters on transcriptional regulation in Saccharomyces cerevisiae: A quantitative analysis of a compendium of chemostat-based transcriptome data
por: Knijnenburg, Theo A, et al.
Publicado: (2009)

Liver metastases of neuroendocrine tumours; early reduction of tumour load to improve life expectancy
por: Veenendaal, Liesbeth M, et al.
Publicado: (2006)

Changes in endogenous cytokines, adhesion molecules and platelets during cytokine-induced tumour necrosis.
por: de Kossodo, S., et al.
Publicado: (1995)

Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer
por: Giardiello, Daniele, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_757u6ipebab166ur18c1p5lt0s